# ESD Versus TAMIS for Early Rectal Neoplasms

> **NCT03217773** · NA · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 114 (estimated)

## Conditions studied

- Rectal Neoplasms

## Interventions

- **PROCEDURE:** ESD
- **PROCEDURE:** TAMIS

## Key facts

- **NCT ID:** NCT03217773
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-01
- **Primary completion:** 2020-07
- **Final completion:** 2020-07
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2019-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03217773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03217773, "ESD Versus TAMIS for Early Rectal Neoplasms". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03217773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*